Keyphrases
Alzheimer's Disease
67%
Magnetic Resonance Imaging
49%
Sporadic Alzheimer's Disease
23%
Cerebrospinal Fluid
22%
Autosomal Dominant Alzheimer's Disease
21%
White Matter
19%
Resting-state Functional Magnetic Resonance Imaging (rs-fMRI)
18%
Functional Magnetic Resonance Imaging
17%
Positron Emission Tomography
17%
Functional Connectivity
15%
Resting-state Functional Connectivity (rs-FC)
15%
Older Adults
14%
Cognitively Normal
13%
Neuroimaging
13%
Diffusion Tensor Imaging
13%
Multiple Sclerosis
13%
Cognitive Impairment
12%
Cognitive Decline
11%
Human Connectome Project
11%
Computed Tomography
10%
Aneurysm
10%
Mutation Carriers
10%
Alzheimer's Disease Biomarkers
10%
Diffusion Magnetic Resonance Imaging (dMRI)
9%
Pittsburgh Compound B
9%
Alzheimer's Disease Pathology
9%
Acute Ischemic Stroke
9%
Radiologists
9%
Tumor
9%
Symptom Onset
9%
Clinical Outcomes
9%
Human Brain
9%
Aging
8%
Gray Matter
8%
Intracranial Aneurysm
8%
Neurodegeneration
8%
Dominantly Inherited Alzheimer's Disease
8%
Amyloid Imaging
8%
Dominantly Inherited Alzheimer Network
8%
Brain Volume
8%
Atrophy
8%
Imaging Biomarkers
7%
Cerebrospinal Fluid Biomarkers
7%
Non-carriers
7%
Contrast Enhancement
7%
White Matter Integrity
7%
Fractional Anisotropy
7%
Amyloid Burden
7%
Pediatric
7%
Temporal Lobe
7%
Clinical Trials
7%
Hippocampal Volume
7%
Dementia
6%
Brain Structure
6%
Pediatric Patients
6%
Gray Matter Volume
6%
Cortical Thickness
6%
Healthy Controls
6%
Endovascular Treatment
6%
Brain Aging
6%
Alzheimer's Dementia
6%
Amyloid Positron Emission Tomography
6%
Brain Regions
6%
Region of Interest
6%
White Matter Hyperintensities
6%
Amyloid PET
6%
Phosphorylated tau
6%
Pediatric multiple Sclerosis
6%
T2-weighted Imaging (T2WI)
6%
Neuroinflammation
6%
Radiology
5%
Tau Positron Emission Tomography
5%
Hippocampus
5%
Longitudinal Change
5%
Standardized Uptake Value
5%
Apolipoprotein E
5%
Mild Cognitive Impairment
5%
Brain Tumor
5%
Central Nervous System
5%
Amyloid Deposition
5%
Apparent Diffusion Coefficient
5%
Early Alzheimer's Disease
5%
Nonhuman Primate
5%
Resting State
5%
Endovascular
5%
Structural Magnetic Resonance Imaging (sMRI)
5%
Catheter
5%
Amyloid beta
5%
Brain MRI
5%
Pipeline Embolization Device
5%
Tau Pathology
5%
Body Mass Index
5%
Obesity
5%
APOE4
5%
Imaging Studies
5%
Endovascular Thrombectomy
5%
Cerebral Blood Flow
5%
T1-weighted
5%
United States
5%
ACR Appropriateness Criteria
5%
Neuroscience
Alzheimer's Disease
100%
Magnetic Resonance Imaging
49%
Amyloid Protein
44%
Magnetic Resonance Imaging
36%
Functional Magnetic Resonance Imaging
34%
Positron Emission Tomography
25%
Cerebrovascular Accident
20%
Functional Connectivity
20%
Positron Emission Tomography
18%
Gray Matter
16%
Diffusion Tensor Imaging
14%
Cognitive Disorders
13%
Diffusion MRI
12%
Multiple Sclerosis
11%
Brain Ischemia
11%
Fluorine-18
11%
Fractional Anisotropy
11%
Neurodegeneration
10%
Resting-State Functional Connectivity
10%
In Vivo
10%
Blood Plasma
9%
Aneurysm
8%
Behavior (Neuroscience)
8%
Hippocampus
8%
Myelin
7%
Temporal Lobe
7%
Body Mass Index
7%
Intracranial Tumor
7%
Tractography
6%
Angiography
6%
Traumatic Brain Injury
6%
Neurotrauma
6%
Metabolic Pathway
6%
Frontal Lobe
6%
Brain Network
6%
Cerebral Cortex
5%
Hydrocephalus
5%
Cerebellum
5%
Beta Amyloid
5%
Gray Matter Volume
5%
Cerebral Hemorrhage
5%
Central Nervous System
5%
Medicine and Dentistry
Alzheimer's Disease
56%
Magnetic Resonance Imaging
48%
Amyloid Protein
30%
Apoplexy
21%
Diseases
20%
Positron Emission Tomography
19%
Tau
19%
Aneurysm
18%
Pediatrics
18%
Biological Marker
16%
Cerebrospinal Fluid
16%
Magnetic Resonance Imaging
14%
Neoplasm
14%
Autosomal Dominant Inheritance
12%
Brain Ischemia
12%
Embolization
11%
Polyethylene Terephthalate
11%
Radiology
10%
Computer Assisted Tomography
10%
Intracranial Aneurysm
9%
Multiple Sclerosis
8%
Pittsburgh Compound B
7%
Diagnosis
7%
Radioactive Tracer
7%
Bleeding
7%
Diffusion MRI
6%
Functional Connectivity
6%
Functional Magnetic Resonance Imaging
6%
Stenosis
6%
Intracranial Tumor
6%
Gray Matter
5%
Ganglioglioma
5%
Pediatrics Patient
5%
Dural Arteriovenous Fistula
5%
Surgery
5%
Clinical Trial
5%
Thrombectomy
5%
Cerebral Hemorrhage
5%
Infarction
5%
Traumatic Brain Injury
5%
Cognitive Defect
5%